mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme

15 participants · First posted Dec 2, 2015

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

72 participants · First posted Apr 7, 2016

A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.

90 participants · First posted Jul 17, 2014

mTORC1 inhibitors, Aeonian

mTORC1 modulators (metabolic disease)

selective mTORC1 modulators, Navitor Pharmaceuticals

Dual mTORC1/2 Inhibitor BI 860585 Shows Promise in Phase I Breast Cancer Trial

Oncotelic Therapeutics Joint Venture Identifies Biomarker Signature for Precision mTOR Inhibitor Therapy

Aeovian Pharmaceuticals Secures $55 Million Series B to Advance First-in-Class mTORC1 Inhibitor for Rare Epilepsy